HACE1
HACE1 is a HECT domain and ankyrin repeat-containing E3 ubiquitin-protein ligase that regulates Golgi membrane fusion and small GTPase signalling. It is also known by the alias KIAA1320 and is considered a potential tumour suppressor. Browse Assay Genie's current range of HACE1 research reagents below, or read on for the biology behind the target.
HACE1 is an E3 ubiquitin-protein ligase involved in Golgi membrane fusion and in the regulation of small GTPases. It acts as a regulator of Golgi membrane dynamics during the cell cycle: it is recruited to the Golgi membrane by Rab proteins and regulates postmitotic Golgi membrane fusion. It does so by mediating ubiquitination during mitotic Golgi disassembly, and this ubiquitination serves as a signal for Golgi reassembly later, after cell division.
HACE1 also specifically binds GTP-bound RAC1. This binding leads to ubiquitination and subsequent degradation of active RAC1, and the activity is linked to a role in host defence against pathogens. In addition, HACE1 may act as a transcription regulator through its interaction with RARB. The protein is found at the Golgi stack membrane, in the cytoplasm and at the endoplasmic reticulum.
The HACE1 gene encodes a protein that carries both a HECT domain and ankyrin repeats, and it belongs to the HECT domain E3 ubiquitin protein ligase and ankyrin repeat domain gene groups. Ubiquitin tagging by the encoded protein directs target proteins towards a particular subcellular localisation or towards proteasomal degradation. HACE1 is regarded as a potential tumour suppressor and has been implicated in the pathophysiology of several tumours, including Wilm's tumour. Orthologues are designated Hace1 in both mouse and rat.
HACE1 regulates postmitotic Golgi membrane fusion, with ubiquitination during disassembly acting as a signal for Golgi reassembly after cell division.
HACE1 binds GTP-bound RAC1 and promotes its ubiquitination and degradation, making it a focus for studies of active RAC1 turnover.
As a HECT-type E3 ligase, HACE1 tags substrates for localisation changes or proteasomal degradation, informing work on ubiquitin signalling.
HACE1 is a potential tumour suppressor implicated in the pathophysiology of several tumours, including Wilm's tumour.
HACE1 is an E3 ubiquitin-protein ligase that regulates Golgi membrane fusion after mitosis and controls small GTPases. It binds GTP-bound RAC1 and drives its ubiquitination and degradation, and it may regulate transcription through its interaction with RARB.
The full name is HECT domain and ankyrin repeat containing E3 ubiquitin protein ligase 1, and UniProt lists it as E3 ubiquitin-protein ligase HACE1. KIAA1320 is a recorded alias. The enzyme is classed under EC 2.3.2.26.
NCBI Gene describes HACE1 as a potential tumour suppressor involved in the pathophysiology of several tumours, including Wilm's tumour. Mouse and rat both carry a Hace1 orthologue; check the datasheet of any product for its validated reactivity.
Small GTPases, nuclear receptors and other HECT-type E3 ubiquitin ligases connected to HACE1 biology.
Gene and protein annotations from HGNC, NCBI Gene and UniProt Q8IYU2; product specifications from Assay Genie datasheets.